Company intelligence / Profile preview

Nuokete

Huzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Nuokete Biopharmaceutical is a China-based biotechnology company focused on the development and commercialization of human vaccines. The company's primary product is a freeze-dried human rabies vaccine produced using advanced Vero cell culture technology, which is marketed within the Chinese healthcare system. Nuokete operates a large-scale, GMP-certified manufacturing base in Huzhou, Zhejiang Province, and is expanding its portfolio to include influenza and tetanus vaccines. By leveraging modern bioprocessing techniques, the company seeks to provide safe and effective immunization solutions for infectious diseases.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Nuokete.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuokete.

Explore the full profile